EcoDrugPlus

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSTBEG00000001589
Gene Symbol: PSENEN
1 Cross references
183 Possible Orthologues:

Prostaglandin D2 Receptor

Ensembl ID : ENSTBEG00000007743
Gene Symbol: PTGDR
1 Cross references
118 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSTBEG00000007013
Gene Symbol: PTGER4
1 Cross references
274 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSTBEG00000014877
Gene Symbol: PTGFR
1 Cross references
195 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSTBEG00000011022
Gene Symbol: PTGS1
1 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSTBEG00000004275
Gene Symbol: PTGS2
1 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSTBEG00000014620
Gene Symbol: PSMA2
1 Cross references
247 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSTBEG00000016910
Gene Symbol: PSMA3
1 Cross references
235 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSTBEG00000011241
Gene Symbol: PSMA6
1 Cross references
272 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSTBEG00000012281
Gene Symbol: PSMA7
1 Cross references
155 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSTBEG00000003980
Gene Symbol: PSMB1
1 Cross references
216 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSTBEG00000003501
Gene Symbol: PSMB10
1 Cross references
171 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).